問卷

TPIDB > Search Result

Search Result

篩選

List

15Cases

2020-01-15 - 2024-12-31

Phase II

Completed
A Phase 2, multicenter study of [18F]APN-1607 positron emission tomography in subjects with Alzheimer’s disease compared to healthy subjects
  • Condition/Disease

    Alzheimer's Disease

  • Test Drug

    [18 F]APN-1607

Participate Sites
4Sites

Recruiting4Sites

2025-08-01 - 2028-07-31

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2024-02-01 - 2029-12-31

Phase III

Completed
Assessment of safety and efficacy of subcutaneous remternetug in early symptomatic Alzheimer’s disease
  • Condition/Disease

    Alzheimer’s disease

  • Test Drug

    injection

Participate Sites
7Sites

Recruiting7Sites

2021-05-18 - 2026-08-21

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2019-04-01 - 2025-12-31

Phase II

Modeling the relationships between functional connectivity and amyloid deposition in Alzheimer’s disease
  • Condition/Disease

    Alzheimer’s disease

  • Test Drug

    F-18 AV-45

Participate Sites
2Sites

Recruiting2Sites

2020-08-01 - 2025-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2021-08-01 - 2024-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2019-01-01 - 2020-12-31

Phase II

Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects
  • Condition/Disease

    Alzheimer's disease

  • Test Drug

    18F-PMPBB3

Participate Sites
2Sites

Recruiting2Sites

2019-08-01 - 2022-07-31

Phase II

A noval tau tracer ([ 18F]PM-PBB3) in young onset dementia: clinical and neuroimaging study
  • Condition/Disease

    *PRESENILE DEMENTIA;SENILE DEMENTIA, UNCOMPLICATED;DEMENTIA IN CONDITIONS CLASSIFIED ELSEWHERE;AMNESTIC  SYNDROME

  • Test Drug

    (1)[F18] AV-45 (2) [F-18] PM-PBB3

Participate Sites
3Sites

Recruiting3Sites

2019-08-01 - 2024-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

1 2